SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) (Parenthetical) - USD ($) |
3 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Oct. 01, 2025 |
Jul. 01, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Nov. 30, 2025 |
|||
| Subsequent Event [Line Items] | |||||||||
| Advances to supplies | [1] | $ 1,458,569 | |||||||
| Professional Fees | $ 189,689.85 | $ 706,157 | $ 711,706 | 1,781,053 | $ 2,889,165 | ||||
| Consulting Agreement [Member] | |||||||||
| Subsequent Event [Line Items] | |||||||||
| Professional Fees | $ 5,500,000 | ||||||||
| Payments for Repurchase of Private Placement | $ 55,000,000 | ||||||||
| Stock Issued During Period, Shares, Other | 220,000,000 | ||||||||
| [custom:ConsultingAgreementDescription] | Accordingly, 148,100,000 shares were issued on a pro-rata basis using the Company’s available authorized shares. The remaining 71,900,000 shares were subject to stockholder approval and an amendment to the Company’s Articles of Incorporation to increase the authorized share capital. As of September 30, 2025, $1,797,500 of the total $5.5 million consulting fee, representing the portion attributable to the 71,900,000 shares not yet issued and therefore had not been settled in equity. Accordingly, this amount was recorded as Other current assets – deferred equity issuance costs. | ||||||||
| Daren Beijing Biomedical Technology Co Ltd [Member] | |||||||||
| Subsequent Event [Line Items] | |||||||||
| Other prepaid inventory | $ 1,404,745 | ||||||||
| Daren Beijing Biomedical Technology Co Ltd [Member] | Subsequent Event [Member] | |||||||||
| Subsequent Event [Line Items] | |||||||||
| Other prepaid inventory | $ 1,404,745 | ||||||||
| |||||||||